SSGCID is one of two Centers recently funded by NIAID in response to RFP-NIH-NIAID-DMID-07-19 and RFP-NIAID-DMID-NIHAI2011124 and is a consortium of four Pacific Northwest institutions ( SeattleBiomed, Beryllium, UW, and Pacific Northwest National Laboratory). The other funded center (CSGID) is based out of Chicago, IL. SSGCID’s primary mission is to determine the structure of ca. 70 protein targets from NIAID Category A-C agents, as well as emerging and re-emerging infectious disease organisms, each year for a period of five years.
|Selection by the scientific community||Targets||Structures|
|Nominated from SSGCID selection||1688||138|
SSGCID is funded by Federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services, under Contract No.: HHSN272201200025C from September 1, 2012. SSGCID was funded under NIAID Contract No.: HHSN272200700057C from September 28, 2007 through September 27, 2012.